Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-14

FDA Approved: TARINA 24 FE — Supplemental Application (Afaxys Pharma, LLC)

View source ↗

Summary

FDA approved a supplemental application for Tarina 24 FE, a combined oral contraceptive containing norethindrone acetate, ethinyl estradiol, and ferrous fumarat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TARINA 24 FE (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE)

Snippet

SUPPL AP for TARINA 24 FE (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE)